Laboratory of Animal Physiology and Phytopharmacology, Faculty of Sciences, University of Dschang, P.O. Box 67, Dschang, Cameroon.
J Ethnopharmacol. 2010 Apr 21;128(3):567-74. doi: 10.1016/j.jep.2010.01.061. Epub 2010 Feb 10.
Dioscorea bulbifera var sativa is a medicinal plant commonly used in Cameroonian traditional medicine to treat pain and inflammation.
The present work evaluated the effects of the methanol extract of the bulbs of Dioscorea bulbifera in inflammatory and neuropathic models of pain and further investigated its possible mechanism of action.
The effects of Dioscorea bulbifera administered orally at the doses of 250 and 500mg/kg were tested in mechanical hypernociception induced by intraplantar (i.pl.) injection of complete Freund's adjuvant (CFA), lipopolysaccharides (LPS) or prostaglandin-E(2) (PGE(2)), as well as in partial ligation sciatic nerve (PLSN), nociception induced by capsaicin and thermal hyperalgesia induced by i.pl. injection of CFA. The therapeutic effects of Dioscorea bulbifera on PGE(2)-induced hyperalgesia were evaluated in the absence and in the presence of l-NAME, an inhibitor of nitric oxide synthase (NOS) and glibenclamide, an inhibitor of ATP-sensitive potassium channels.
The extract showed significant antinociceptive effects in persistent pain induced by CFA and on neuropathic pain induced by PLSN. The effects of Dioscorea bulbifera persisted for 5 days after two administrations in CFA-induced hypernociception. Dioscorea bulbifera significantly inhibited acute LPS-induced pain but failed to reduce thermal hypernociception and capsaicin-induced spontaneous nociception. The antinociceptive effects of this plant extract in PGE(2) model was antagonized by either l-NAME or glibenclamide.
Present demonstrate the antinociceptive activities of Dioscorea bulbifera both in inflammatory and neuropathic models of pain and these effects may result, at least partially, from its ability to activate the NO-cGMP-ATP-sensitive potassium channels pathway.
盾叶薯蓣(Dioscorea bulbifera var sativa)是一种药用植物,常用于喀麦隆传统医学治疗疼痛和炎症。
本研究评估了盾叶薯蓣块茎甲醇提取物在炎性和神经性疼痛模型中的作用,并进一步研究了其可能的作用机制。
采用足底注射完全弗氏佐剂(CFA)、脂多糖(LPS)或前列腺素 E2(PGE2)、坐骨神经部分结扎(PSLN)、辣椒素诱导的伤害性感受和足底注射 CFA 诱导的热痛觉过敏等方法,评价口服 250 和 500mg/kg 剂量的盾叶薯蓣的作用。在不存在和存在一氧化氮合酶(NOS)抑制剂 l-NAME 和三磷酸腺苷敏感性钾通道抑制剂格列本脲的情况下,评价盾叶薯蓣对 PGE2 诱导的痛觉过敏的治疗作用。
提取物在 CFA 诱导的持续性疼痛和 PLSN 诱导的神经性疼痛模型中表现出显著的镇痛作用。在 CFA 诱导的痛觉过敏中,两次给药后,盾叶薯蓣的作用持续了 5 天。盾叶薯蓣显著抑制急性 LPS 诱导的疼痛,但未能减轻热痛觉过敏和辣椒素诱导的自发性疼痛。该植物提取物在 PGE2 模型中的镇痛作用被 l-NAME 或格列本脲拮抗。
本研究表明盾叶薯蓣具有抗炎和神经病理性疼痛模型的镇痛活性,这些作用至少部分是由于其激活一氧化氮-cGMP-三磷酸腺苷敏感性钾通道途径的能力所致。